Skip to main content

Additional Articles by the Authors

Craig White, PhD
Winghan Jacqueline Kwong, PharmD, PhD
Hilary Armstrong, PhD
Michael Behling
Jeffrey Niemira
Kathy Lang, PhD
Business, Original Research
Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization
Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH
Stakeholder Perspective
Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
Atheer A. Kaddis, PharmD
Read More
Clinical
Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting
Stakeholder Perspective
Better Compliance with Clinical Guidelines for Venous Thromboembolism Can Improve Patient Outcomes, Reduce Costs
Read More
Business
The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis
Stakeholder Perspective
The Clinical Toll of Nonvalvular Atrial Fibrillation Poses Significant Economic Burden
Read More
Business
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Stakeholder Perspective
Warfarin Utilization in Medicare Patients with Nonvalvular Atrial Fibrillation: Sentinel Data from an Administrative Claims Database
Read More

Results 1 - 4 of 4